PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue90,71492,78260,594
Cost of Revenue46,55439,33237,192
Gross Profit44,16053,45023,402
Operating Expenses
Research Development67,61760,44048,230
Selling General and Administrative47,78722,14438,026
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-71,244-29,134-62,854
Income from Continuing Operations
Total Other Income/Expenses Net103364-478
Earnings Before Interest and Taxes-71,141-28,770-63,332
Interest Expense3,2342,9262,828
Income Before Tax-74,375-31,696-66,160
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-74,375-31,696-66,160
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-74,375-31,696-66,160
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-74,375-31,696-66,160